There are 412 resources available
Presentation of case/condition
Presenter: Johan Vansteenkiste
Session: Managing stage III NSCLC in the era of IO
Resources:
Slides
Webcast
1298P - Chemotherapy with concurrent proton vs. photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and immune therapy
Presenter: Francesco Cortiula
Session: Poster session 04
IO after or with chemoradiotherapy? For how long?
Presenter: Johan Vansteenkiste
Session: Managing stage III NSCLC in the era of IO
Resources:
Slides
Webcast
Introduction and definition of oligometastatic disease(s) + Case presentation
Presenter: Anne-Marie Dingemans
Session: Management of oligometastatic disease in NSCLC
Resources:
Slides
Webcast
Invited Discussant 1262MO and 1263MO
Presenter: Kersti Oselin
Session: Mini oral session 1 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Invited Discussant 1312MO and 1313MO
Presenter: Lizza Hendriks
Session: Mini oral session 1 - NSCLC, metastatic
Resources:
Slides
Webcast
Improving HER2 Targeting in NSCLC with Selective TKI
Presenter: Zofia Piotrowska
Session: Boehringer Ingelheim - Rethinking Cancer Therapies: Fresh Perspectives on MDM2-p53, HER2, DLL3 and Other Targets in Cancer
Resources:
Webcast
Invited Discussant LBA57, 1264MO, LBA58 and LBA59
Presenter: Edward Garon
Session: Mini oral session 2 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Invited Discussant LBA61, 1292MO, LBA62 and 1293MO
Presenter: Matthias Guckenberger
Session: Mini oral session 2 - Non-metastatic NSCLC and other thoracic malignancies
Resources:
Slides
Webcast
Conclusions and perspectives
Presenter: Sanjay Popat
Session: Open questions in immunotherapy for advanced NSCLC: Duration of IO, combinations and rechallenge
Resources:
Webcast